blood clots and glp 1 GLP-1 meds might reduce clot risk in diabetes patients GLP-1 Therapies May Benefit MPN

Ocular and Psychiatric Safety Signals Retinopathy and neuropsychiatric outcomes have generated additional safety discussions

Wnt signaling inhibitor characteristics according to bone status and physical activity levels in young and middle-aged premenopausal women

In the DUAL V, 40% of patients assuming Liraglutide/Degludec received 50 dose steps after 26 weeks corresponding to 1.8 mg of Liraglutide, with a wide range of variability also depending on baseline BMI (65)

Resistance training protects muscle mass during rapid weight loss

A separate analysis of the STEP 1 data found that lean mass was reduced by 6.92 kg with a total weight reduction of 15.3 kg, meaning roughly 45 percent of the weight lost was lean mass